Trikafta
Midweek Mediawatch: A good news story gone bad
In this week's edition of Midweek Mediawatch, Hayden Donnell talks to Karyn Hay about a media tussle with Pharmac, a so-called 'trainweck' interview by the broadcasting minister and two interesting… Audio
Midweek Mediawatch: A good news story gone bad
In this week's edition of Midweek Mediawatch, Hayden Donnell talks to Karyn Hay about a media tussle with Pharmac, a so-called 'trainweck' interview by the broadcasting minister and two interesting…
AudioPiling on pressure for a costly ‘miracle’ drug
Last year Newshub put its weight behind a campaign to fund a treatment for cystic fibrosis from the public purse even though the cost was sky-high and the US-based maker never applied to register it… Audio
Piling on pressure for a costly ‘miracle’ drug
Last year Newshub put its weight behind a campaign to fund a treatment for cystic fibrosis from the public purse even though the cost was sky-high and the US-based maker never applied to register it…
AudioHurdles remain in place for teen on $470k life-saving drug
At 15, Bella Powell was told she had only two years to live if her CF went untreated. With nothing to lose, Bella, now 17, started taking a drug called Trikafta, and within hours she noticed results… Audio
Controversial campaign for costly new drug
Newshub has put its weight behind a campaign to fund a “miracle drug” for cystic fibrosis patients from the public purse. But are its viewers getting the full picture? Audio
Controversial campaign for costly new drug
Newshub has put its weight behind a campaign to fund a “miracle drug” for cystic fibrosis patients from the public purse. But are its viewers getting the full picture?
Audio